Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr. Daan De Maeseneer, Oncologie from Gent, company number BE0687526397, closed financial year 2025 with a result of € 48,012 after tax. For that financial year Dr. Daan De Maeseneer, Oncologie recorded a gross margin of € 141,448 and equity of € 481,752. Compared with financial year 2024, the result moved from € 67,986 to € 48,012. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.
€ 481,752
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 48,012
▼ 29% vs 2024
Profit after tax over the fiscal year.
€ 33,404
▲ € 28,000 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 463,152.
People and assets in 2025
€ 59,082
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 600,227
▼ 3% vs 2024
€ 61,663 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 34,367
▲ € 25,845 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,616
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 106,731 | € 233,843 | € 152,734 | € 141,448 | ▼ 7% |
| Profit after taxes | € 40,599 | € 143,401 | € 67,986 | € 48,012 | ▼ 29% |
| Equity | € 222,353 | € 365,754 | € 433,740 | € 481,752 | ▲ 11% |
| Total debts | € 240,158 | € 196,600 | € 637,272 | € 642,210 | ▲ 1% |
| Cash | € 8,983 | € 92,849 | € 5,404 | € 33,404 | ▲ € 28,000 |
| Land & buildings | - | - | € 520,055 | € 519,661 | |
| Retained profit | € 203,753 | € 347,154 | € 415,140 | € 463,152 | ▲ 12% |
| Bank debt | € 198,440 | € 152,127 | € 621,134 | € 600,227 | ▼ 3% |
| Balance sheet total | € 462,511 | € 562,354 | € 1,071,012 | € 1,123,962 | ▲ 5% |
Key figures of Dr. Daan De Maeseneer, Oncologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Daan De Maeseneer, Oncologie?
What happened at Dr. Daan De Maeseneer, Oncologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 48,012 (▼ 29% vs 2024). filed late Source: NBB ↗
- Lies Puttemans became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 40,599 profit in 2022 to € 48,012 profit in 2025.
Paid € 83,046 in corporate taxes since 2022.
Best year ever: 2023, with € 143,401 profit.
Management
Behind Dr. Daan De Maeseneer, Oncologie are Lies Puttemans and Daan De Maeseneer.
Directors
According to the 2025 annual accounts
Lies Puttemans
Director
since 2024
Daan De Maeseneer
Director
Establishments
Establishment units
Physical locations of this company
Jan van Aelbroecklaan 30
9050 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0687.526.397
- VAT number
- BE 0687.526.397
- Registered office
- Jan van Aelbroecklaan 30, 9050 Gent
- Names & denominations
- Dr. Daan De Maeseneer, Oncologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2018
- Peppol
- Not registered